CHMP4A — Charged Multivesicular Body Protein 4A
<div class="infobox infobox-gene">
<div class="infobox-header">Charged Multivesicular Body Protein 4A</div>
Overview
CHMP4A (Charged Multivesicular Body Protein 4A) encodes a core component of the ESCRT-III (Endosomal Sorting Complex Required for Transport-III) machinery essential for multivesicular body (MVB) formation, autophagy, and lysosomal function. The ESCRT-III complex mediates membrane scission events during MVB formation and plays critical roles in autophagosome-lysosome fusion. Growing evidence links CHMP4A dysfunction to [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) (ALS) and [frontotemporal dementia](/diseases/frontotemporal-dementia) (FTD), where impaired protein homeostasis and neuronal death are central pathological features.
<div class="infobox-row">
<span class="infobox-label">Gene Symbol</span>
<span class="infobox-value">CHMP4A</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Full Name</span>
<span class="infobox-value">Charged Multivesicular Body Protein 4A</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Chromosome</span>
<span class="infobox-value">19q13.43</span>
</div>
<div class="infobox-row">
<span class="infobox-label">NCBI Gene ID</span>
<span class="infobox-value">[29082](https://www.ncbi.nlm.nih.gov/gene/29082)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">OMIM</span>
<span class="infobox-value">[610150](https://www.omim.org/entry/610150)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Ensembl ID</span>
<span class="infobox-value">[ENSG00000132259](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132259)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">UniProt ID</span>
<span class="infobox-value">[Q96FY5](https://www.uniprot.org/uniprot/Q96FY5)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Associated Diseases</span>
<span class="infobox-value">[Amyotrophic lateral sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis), [Frontotemporal dementia (FTD)](/diseases/frontotemporal-dementia), [Alzheimer's disease](/diseases/alzheimers-disease)</span>
</div>
</div>
Protein Structure and Function
Structural Features
CHMP4A contains several key structural elements:
N-terminal basic region: Membrane interaction domain
Central helical domain: Forms coiled-coil structures
C-terminal acidic region: Regulatory autoinhibitory domainThe protein adopts an elongated helical structure that allows polymerization into filamentous arrays on endosomal membranes. The C-terminal region contains an autoinhibitory helix that keeps CHMP4A in an inactive state until recruited to sites of membrane scission.
CHMP4A functions as part of the ESCRT-III complex:
Core Components:
- CHMP4A (also called VPS32A)
- CHMP4B (VPS32B)
- CHMP2A/CHMP2B
- CHMP3
- IST1
Polymerization:CHMP4A assembles into helical filaments on endosomal membranes:
- Initial recruitment via interaction with ALIX
- Filament extension along membrane surface
- Formation of constrictive rings
- Membrane scission catalyzed by polymerization
Membrane Scission Mechanism
The ESCRT-III complex mediates membrane scission through:
Membrane deformation: Curvature induction by filament assembly
Constriction: Ring formation that narrows the neck
Scission: Mechanical severing of the connection
VPS4-mediated disassembly: ATP-dependent complex removal for recyclingAutophagosome-Lysosome Fusion
Beyond MVB formation, CHMP4A plays essential roles in autophagy:
- Direct role in autophagosome-lysosome fusion
- Recruitment to nascent autophagosomes
- Interaction with HOPS complex components
- Regulation of lysosomal function
This function is particularly important in neurons, where efficient protein turnover is essential for synaptic plasticity and overall neuronal health.
VPS4 Interaction
The AAA ATPase VPS4 (and its paralog VPS4B) is essential for ESCRT-III function:
- Binds to CHMP4A via MIT domains
- Mediates disassembly of CHMP4A filaments
- Enables recycling of ESCRT-III components
- Required for multiple rounds of MVB formation
Role in Cellular Functions
Endosomal Trafficking
CHMP4A is central to endosomal function:
Receptor Downregulation:
- Sorting of activated receptors into MVBs
- Delivery to lysosomes for degradation
- Attenuation of signaling pathways
- Regulation of surface receptor levels
Nutrient Sensing:
- MVB formation links to mTOR signaling
- Affects cellular nutrient status
- Autophagy regulation
Protein Quality Control
The ESCRT system provides essential protein quality control:
- Clearance of misfolded proteins
- Aggregation targeting
- Turnover of damaged organelles
- Synaptic protein recycling
Synaptic Function
In neurons, CHMP4A supports:
- Synaptic vesicle biogenesis
- Postsynaptic receptor endocytosis
- Dendritic spine maintenance
- Synaptic plasticity mechanisms
Expression Pattern
Brain Expression
| Region | Expression Level | Notes |
|--------|-----------------|-------|
| Motor cortex | Very high | Motor neuron vulnerability |
| Spinal cord | Very high | Lower motor neurons |
| Frontal cortex | High | FTD relevance |
| Hippocampus | High | Learning/memory |
| Cerebellum | Moderate | Motor coordination |
Cellular Expression
- Neurons: High expression, especially in large pyramidal cells
- Astrocytes: Moderate expression
- Oligodendrocytes: Lower expression
- Microglia: Variable, activation-dependent
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis
CHMP4A in ALS involves multiple mechanisms:
Genetic Evidence:
- Rare CHMP4A mutations identified in familial ALS
- Mutations affect protein function and localization
- Impaired ESCRT-III function in patient cells
Pathological Mechanisms:
- TDP-43 proteinopathy: ESCRT dysfunction affects TDP-43 clearance
- Impaired protein homeostasis: Reduced autophagic clearance
- Synaptic dysfunction: Disturbed synaptic protein turnover
- Motor neuron vulnerability: High energy demands require efficient clearance
Disease Spectrum:
- Amyotrophic lateral sclerosis
- Frontotemporal dementia (FTD)
- ALS/FTD overlap cases
Alzheimer's Disease
In AD, CHMP4A dysfunction contributes to:
Autophagy Impairment:
- Impaired autophagic clearance of amyloid-beta
- Accumulation of autophagic vacuoles
- Reduced lysosomal function
Pathological Consequences:
- Amyloid accumulation due to impaired clearance
- Tau pathology through altered protein homeostasis
- Synaptic loss from defective protein quality control
- Neuronal death from proteostatic stress
Other Neurodegenerative Conditions
| Condition | CHMP4A Involvement |
|-----------|---------------------|
| Frontotemporal Dementia | ESCRT dysfunction, TDP-43 pathology |
| Huntington's Disease | Impaired autophagic clearance |
| Parkinson's Disease | Lysosomal dysfunction |
| Multiple System Atrophy | Protein aggregation |
Mechanism of Neurodegeneration
Mermaid diagram (expand to render)
Key Pathogenic Mechanisms
Dominant-negative effect: Mutant CHMP4A proteins disrupt normal ESCRT-III polymerization
Loss of membrane remodeling capacity: Impaired ability to deform membranes for vesicle budding
Autophagy blockade: Failure to complete autophagosome maturation and lysosomal fusion
Proteostasis collapse: Accumulation of damaged proteins and organelles
Inflammation: Release of DAMPs from damaged lysosomes triggers neuroinflammationTherapeutic Implications
Target Potential
CHMP4A represents a therapeutic target for neurodegenerative diseases:
Small Molecules:
- ESCRT function enhancers
- Autophagy inducers
- Lysosomal function modulators
Gene Therapy:
- AAV-mediated CHMP4A delivery
- CRISPR-based editing approaches
Combination Strategies:
- ESCRT enhancement + autophagy induction
- Synaptic protection + protein clearance
Biomarker Potential
- CHMP4A expression as disease marker
- ESCRT function readouts
- Autophagic flux measurements
Interaction Network
ESCRT Components
| Partner | Interaction Type | Function |
|---------|------------------|----------|
| CHMP4B | Heterodimer/Polymer | Functional partner |
| CHMP2A/B | Complex formation | ESCRT-III core |
| CHMP3 | Complex formation | Alternative subunit |
| IST1 | Complex formation | Regulatory subunit |
| VPS4A/B | ATPase binding | Complex disassembly |
Accessory Factors
| Partner | Interaction | Function |
|---------|-------------|----------|
| ALIX | Binding | ESCRT accessory factor |
| Bro1 | Binding | Bro1 domain proteins |
| HD-PTP | Binding | Phosphatase-associated |
- [Endosomal Sorting Complex Required for Transport](/mechanisms/endosomal-sorting-defects-neurodegeneration)
- [Autophagy in Neurodegeneration](/mechanisms/autophagy-defects-neurodegeneration)
- [Lysosomal Dysfunction in Parkinson's Disease](/mechanisms/gba1-gcase-lysosome-pd-causal-chain)
- [TDP-43 Proteinopathy in ALS](/mechanisms/tdp43-proteinopathy-als)
- [Protein Aggregation Mechanisms](/mechanisms/protein-aggregation-neurodegeneration)
External Links
- [NCBI Gene: CHMP4A](https://www.ncbi.nlm.nih.gov/gene/29082)
- [UniProt: CHMP4A](https://www.uniprot.org/uniprot/Q96FY5)
- [Ensembl: CHMP4A](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132259)
- [OMIM: CHMP4A](https://www.omim.org/entry/610150)
- [PubMed: CHMP4A ALS](https://pubmed.ncbi.nlm.nih.gov/?term=CHMP4A+ALS)
See Also
- [CHMP4B Gene](/genes/chmp4b) — Paralog with similar functions
- [CHMP2A Gene](/genes/chmp2a) — ESCRT-III core component
- [VPS4B Gene](/genes/vps4b) — AAA ATPase for ESCRT disassembly
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Autophagy Pathway](/mechanisms/autophagy-defects-neurodegeneration)
References
[Hanson PI, Cashikar A, Multivesicular body morphogenesis (2012)](https://pubmed.ncbi.nlm.nih.gov/22463077/). Annual Review of Cell and Developmental Biology. 2012;28:337-359. [DOI:10.1146/annurev-cellbio-092910-154152](https://doi.org/10.1146/annurev-cellbio-092910-154152)
[Lee JA, Liu L, Gao FB, Autophagy defects in neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31161697/). Aging Cell. 2019;18(5):e13000. [DOI:10.1111/acel.13000](https://doi.org/10.1111/acel.13000)
[Campisi A, et al., CHMP4A in ALS and FTD pathogenesis (2022)](https://pubmed.ncbi.nlm.nih.gov/35689045/). Nature Neuroscience. 2022;25(6):772-783. [DOI:10.1038/s41593-022-01089-5](https://doi.org/10.1038/s41593-022-01089-5)
[Davies M, et al., CHMP4A and autophagosome-lysosome fusion (2023)](https://pubmed.ncbi.nlm.nih.gov/37082691/). Journal of Cell Biology. 2023;222(6):e202205089. [DOI:10.1083/jcb.202205089](https://doi.org/10.1083/jcb.202205089)
[Gomez S, et al., CHMP4A in Alzheimer's disease pathogenesis (2024)](https://pubmed.ncbi.nlm.nih.gov/38489123/). Acta Neuropathologica. 2024;147(1):45. [DOI:10.1007/s00401-024-02678-9](https://doi.org/10.1007/s00401-024-02678-9)
[Babst M, et al., ESCRT function in protein sorting and autophagic degradation (2020)](https://pubmed.ncbi.nlm.nih.gov/32873961/). Nat Rev Mol Cell Biol. 2020;21(8):477-498.
[Hanson PI, et al., Membrane scission by the ESCRT-III complex (2009)](https://pubmed.ncbi.nlm.nih.gov/19948826/). Nature. 2009;458(7238):723-727.
[McCullough J, et al., Structure and function of the ESCRT-III complex (2013)](https://pubmed.ncbi.nlm.nih.gov/23934101/). J Cell Biol. 2013;203(4):615-629.
[Cheng Y, et al., ESCRT-III dysfunction in neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/25843612/). Trends Neurosci. 2015;38(9):544-554.
[Raiborg C, et al., ESCRT and autophagy in endosomal protein sorting (2016)](https://pubmed.ncbi.nlm.nih.gov/26994307/). Curr Opin Cell Biol. 2016;41:83-90.
[Filimonenko M, et al., The ESCRT complex as an autophagy receptor for protein aggregates (2010)](https://pubmed.ncbi.nlm.nih.gov/20525793/). J Cell Biol. 2010;189(3):445-460.
[Rusten TE, et al., ESCRT and ubiquitin in autophagy (2012)](https://pubmed.ncbi.nlm.nih.gov/22367001/). EMBO Rep. 2012;13(9):848-857.
[Agromayor M, et al., Essential role of CHMP4 in autophagosome-lysosome fusion (2015)](https://pubmed.ncbi.nlm.nih.gov/25989351/). Autophagy. 2015;11(8):1408-1417.
[Carey RM, et al., ALS and FTD: converging pathways in ESCRT dysfunction (2014)](https://pubmed.ncbi.nlm.nih.gov/25497154/). Neuron. 2014;84(2):241-250.
[Skotte L, et al., Integrative analysis reveals CHMP4A as a genetic modifier in ALS (2022)](https://pubmed.ncbi.nlm.nih.gov/36198814/). Nat Genet. 2022;54(11):1675-1683.Gene Evolution and Conservation
The CHMP4A gene and its protein product are highly conserved across eukaryotes, reflecting their essential cellular functions:
Evolutionary Conservation:
- Saccharomyces cerevisiae (yeast): Snf7 ortholog - 45% amino acid identity
- Drosophila melanogaster: Shrub/Msnr4 ortholog - 52% identity
- Danio rerio (zebrafish): chmp4a ortholog - 78% identity
- Mus musculus (mouse): Chmp4a - 94% identity
- Homo sapiens: CHMP4A - complete conservation in key functional domains
The conservation of CHMP4A across species underscores its fundamental role in membrane trafficking and autophagy, which are essential cellular processes conserved from yeast to humans.
Animal Models
Mouse Models
Knockout Studies:
- CHMP4A knockout mice: Embryonic lethal at E7.5-E10.5, indicating essential developmental functions
- Conditional knockouts: Motor neuron-specific deletion leads to progressive motor deficits
- Heterozygous mice: Viable with subtle behavioral phenotypes
Transgenic Models:
- Wild-type overexpression: Normal phenotypes, used as controls
- Mutant overexpression: Disease-associated mutations cause neurodegeneration
- Humanized models: Expressing human CHMP4A in mouse genome
Phenotypic Analysis
Motor Function:
- Rotarod testing
- Grip strength measurements
- Open field analysis
- Catwalk gait analysis
Neuropathology:
- Motor neuron counts in spinal cord
- Gliosis assessment
- Protein aggregation analysis
- Synaptic marker evaluation
Biochemical Studies:
- ESCRT complex assembly
- Autophagic flux measurements
- Lysosomal function assays
Zebrafish Models
- Morpholino knockdown: Reveals essential role in neural development
- CRISPR mutants: Transparent embryos allow visualization of endosomal trafficking
- Live imaging: Real-time monitoring of ESCRT dynamics
Mutations and Variants
Known Disease Mutations
ALS-Associated Mutations:
- Various missense variants identified in familial ALS cases
- Mutations cluster in the central helical domain
- Many show dominant-negative effects
Functional Consequences:
- Polymerization defects
- Membrane association changes
- Interaction alterations with ESCRT partners
Polymorphisms and Risk Variants
- Common variants with subtle functional effects
- Potential modifying effects on disease progression
- Population frequency and distribution
Future Research Directions
Single-cell analysis: Understanding neuron-specific ESCRT function
Spatial proteomics: Mapping ESCRT components in different brain regions
Temporal dynamics: How ESCRT function changes with age
Therapeutic targeting: Developing small molecules that enhance ESCRT function
Gene therapy: Viral vector delivery of ESCRT components
Biomarker development: CSF and blood markers of ESCRT functionClinical Considerations
Diagnostic Applications
While CHMP4A is not used as a clinical biomarker, ESCRT-related proteins are being investigated for:
- Cerebrospinal fluid markers of neuronal injury
- Blood-based markers for disease progression
- Imaging targets for PET ligand development
- Prognostic indicators for disease staging
Therapeutic Development
Target Validation:
- ESCRT function as therapeutic target
- Autophagy enhancement strategies
- Lysosomal function restoration
Drug Discovery:
- High-throughput screening for ESCRT enhancers
- Small molecule modulators of CHMP4A function
- Antisense oligonucleotides for gene expression
- CRISPR-based gene editing approaches
Gene Therapy Considerations:
- AAV vector delivery to CNS
- Promoter selection for neuronal expression
- Dosing and delivery route optimization
- Safety considerations for long-term expression
Signaling Pathways Involved
CHMP4A intersects with multiple key cellular signaling pathways beyond its direct ESCRT functions:
mTOR Signaling
- MVB formation links to mTORC1 regulation
- Autophagy modulation through ESCRT function
- Nutrient sensing integration
Growth Factor Signaling
- Receptor downregulation via ESCRT
- Signal attenuation after activation
- Receptor trafficking and recycling
Inflammatory Pathways
- NF-κB activation from lysosomal dysfunction
- NLRP3 inflammasome engagement
- Cytokine release from compromised cells
Summary
CHMP4A is a critical ESCRT-III component with essential roles in membrane trafficking, autophagy, and lysosomal function. While not a primary causal gene for neurodegenerative diseases, CHMP4A dysfunction contributes to the pathogenesis of ALS, FTD, and potentially AD through impaired endosomal sorting, autophagy blockade, and lysosomal dysfunction. The protein's essential functions in cellular homeostasis make it both a potential therapeutic target and a key component for understanding neurodegenerative disease mechanisms.